A. Ishida-yamamoto et al., Mutant loricrin is not crosslinked into the cornified cell envelope but istranslocated into the nucleus in loricrin keratoderma, J INVES DER, 115(6), 2000, pp. 1088-1094
Loricrin is a major constituent of the epidermal cornified cell envelope. W
e have recently identified heterozygous loricrin gene mutations in two domi
nantly inherited skin diseases, the ichthyotic variant of Vohwinkel syndrom
e and progressive symmetric erythrokeratoderma, collectively termed loricri
n keratoderma. In order to see whether the mutant loricrin molecules predic
ted by DNA sequencing are expressed in vivo and to define their pathologic
effects, we raised antibodies against synthetic peptides corresponding to t
he mutated sequences of loricrin. Immunoblotting of horny cell extracts fro
m loricrin keratoderma patients showed specific bands for mutant loricrin.
Immunohistochemistry of loricrin keratoderma skin biopsies showed positive
immunoreactivity to the mutant loricrin antibodies in the nuclei of differe
ntiated epidermal keratinocytes. The immunostaining was localized to the nu
cleoli of the lower granular cell layer. As keratinocyte differentiation pr
ogressed the immunoreactivity moved gradually into the nucleoplasm leaving
nucleoli mostly nonimmunoreactive. No substantial staining was observed alo
ng the cornified cell envelope. This study confirmed that mutant loricrin w
as expressed in the loricrin keratoderma skin. Mutant loricrin, as a domina
nt negative disrupter, is not likely to affect cornified cell envelope cros
slinking directly, but seems to interfere with nuclear/nucleolar functions
of differentiating keratinocytes. In addition, detection of the mutant lori
crin in scraped horny layer could provide a simple noninvasive screening te
st for loricrin keratoderma.